Scholar Rock Holding Corp (SRRK)
13.35
-1.20
(-8.25%)
USD |
NASDAQ |
May 10, 16:00
13.34
-0.02
(-0.11%)
After-Hours: 20:00
Scholar Rock Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | -23.95% |
| December 31, 2021 | -887.0% |
| September 30, 2021 | -686.4% |
| June 30, 2021 | -668.3% |
| March 31, 2021 | -587.7% |
| December 31, 2020 | -773.3% |
| September 30, 2020 | -775.8% |
| Date | Value |
|---|---|
| June 30, 2020 | -494.4% |
| March 31, 2020 | -339.4% |
| December 31, 2019 | -152.8% |
| September 30, 2019 | -338.2% |
| June 30, 2019 | -248.6% |
| March 31, 2019 | -346.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-887.0%
Minimum
Dec 2021
-23.95%
Maximum
Mar 2022
-498.0%
Average
-541.1%
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | -1.52% |
| Eli Lilly and Co | 25.58% |
| Ocular Therapeutix Inc | -438.9% |
| Alpine Immune Sciences Inc | 19.32% |
| X4 Pharmaceuticals Inc | -- |